United States Trigeminal Neuralgia Therapeutics Market Report 2018

January 2018 | 96 pages | ID: U8989050CA7EN
QYResearch

Abstracts

In this report, the United States Trigeminal Neuralgia Therapeutics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Trigeminal Neuralgia Therapeutics in these regions, from 2013 to 2025 (forecast).

United States Trigeminal Neuralgia Therapeutics market competition by top manufacturers/players, with Trigeminal Neuralgia Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Allergan, Inc.
• Biogen, Inc.
• Kineta, Inc.
• Merz Pharma GmbH & Co. KgaA
• Trigemina, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• NeuroRelease TN
• Onabotulinumtoxin A
• Oxytocin
• Raxatrigine Hydrochloride
• U-2902
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Trigeminal Neuralgia Therapeutics Market Report 2018

1 TRIGEMINAL NEURALGIA THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Trigeminal Neuralgia Therapeutics
1.2 Classification of Trigeminal Neuralgia Therapeutics by Product Category
  1.2.1 United States Trigeminal Neuralgia Therapeutics Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Trigeminal Neuralgia Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 NeuroRelease TN
  1.2.4 Onabotulinumtoxin A
  1.2.5 Oxytocin
  1.2.6 Raxatrigine Hydrochloride
  1.2.7 U-2902
  1.2.8 Others
1.3 United States Trigeminal Neuralgia Therapeutics Market by Application/End Users
  1.3.1 United States Trigeminal Neuralgia Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Trigeminal Neuralgia Therapeutics Market by Region
  1.4.1 United States Trigeminal Neuralgia Therapeutics Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Trigeminal Neuralgia Therapeutics Status and Prospect (2013-2025)
  1.4.3 Southwest Trigeminal Neuralgia Therapeutics Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Trigeminal Neuralgia Therapeutics Status and Prospect (2013-2025)
  1.4.5 New England Trigeminal Neuralgia Therapeutics Status and Prospect (2013-2025)
  1.4.6 The South Trigeminal Neuralgia Therapeutics Status and Prospect (2013-2025)
  1.4.7 The Midwest Trigeminal Neuralgia Therapeutics Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Trigeminal Neuralgia Therapeutics (2013-2025)
  1.5.1 United States Trigeminal Neuralgia Therapeutics Sales and Growth Rate (2013-2025)
  1.5.2 United States Trigeminal Neuralgia Therapeutics Revenue and Growth Rate (2013-2025)

2 UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Trigeminal Neuralgia Therapeutics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Trigeminal Neuralgia Therapeutics Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Trigeminal Neuralgia Therapeutics Average Price by Players/Suppliers (2013-2018)
2.4 United States Trigeminal Neuralgia Therapeutics Market Competitive Situation and Trends
  2.4.1 United States Trigeminal Neuralgia Therapeutics Market Concentration Rate
  2.4.2 United States Trigeminal Neuralgia Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Trigeminal Neuralgia Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Trigeminal Neuralgia Therapeutics Sales and Market Share by Region (2013-2018)
3.2 United States Trigeminal Neuralgia Therapeutics Revenue and Market Share by Region (2013-2018)
3.3 United States Trigeminal Neuralgia Therapeutics Price by Region (2013-2018)

4 UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Trigeminal Neuralgia Therapeutics Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Trigeminal Neuralgia Therapeutics Revenue and Market Share by Type (2013-2018)
4.3 United States Trigeminal Neuralgia Therapeutics Price by Type (2013-2018)
4.4 United States Trigeminal Neuralgia Therapeutics Sales Growth Rate by Type (2013-2018)

5 UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Trigeminal Neuralgia Therapeutics Sales and Market Share by Application (2013-2018)
5.2 United States Trigeminal Neuralgia Therapeutics Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Allergan, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Trigeminal Neuralgia Therapeutics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Allergan, Inc. Trigeminal Neuralgia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Biogen, Inc.
  6.2.2 Trigeminal Neuralgia Therapeutics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Biogen, Inc. Trigeminal Neuralgia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Kineta, Inc.
  6.3.2 Trigeminal Neuralgia Therapeutics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Kineta, Inc. Trigeminal Neuralgia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Merz Pharma GmbH & Co. KgaA
  6.4.2 Trigeminal Neuralgia Therapeutics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merz Pharma GmbH & Co. KgaA Trigeminal Neuralgia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Trigemina, Inc.
  6.5.2 Trigeminal Neuralgia Therapeutics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Trigemina, Inc. Trigeminal Neuralgia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview

7 TRIGEMINAL NEURALGIA THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Trigeminal Neuralgia Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Trigeminal Neuralgia Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Trigeminal Neuralgia Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Trigeminal Neuralgia Therapeutics Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Trigeminal Neuralgia Therapeutics Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Trigeminal Neuralgia Therapeutics Sales Volume Forecast by Type (2018-2025)
11.3 United States Trigeminal Neuralgia Therapeutics Sales Volume Forecast by Application (2018-2025)
11.4 United States Trigeminal Neuralgia Therapeutics Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Trigeminal Neuralgia Therapeutics
Figure United States Trigeminal Neuralgia Therapeutics Market Size (K Pcs) by Type (2013-2025)
Figure United States Trigeminal Neuralgia Therapeutics Sales Volume Market Share by Type (Product Category) in 2017
Figure NeuroRelease TN Product Picture
Figure Onabotulinumtoxin A Product Picture
Figure Oxytocin Product Picture
Figure Raxatrigine Hydrochloride Product Picture
Figure U-2902 Product Picture
Figure Others Product Picture
Figure United States Trigeminal Neuralgia Therapeutics Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Trigeminal Neuralgia Therapeutics by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Trigeminal Neuralgia Therapeutics Market Size (Million USD) by Region (2013-2025)
Figure The West Trigeminal Neuralgia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Trigeminal Neuralgia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Trigeminal Neuralgia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Trigeminal Neuralgia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Trigeminal Neuralgia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Trigeminal Neuralgia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Trigeminal Neuralgia Therapeutics Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Trigeminal Neuralgia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Trigeminal Neuralgia Therapeutics Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Trigeminal Neuralgia Therapeutics Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Trigeminal Neuralgia Therapeutics Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Trigeminal Neuralgia Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Trigeminal Neuralgia Therapeutics Sales Share by Players/Suppliers
Figure United States Trigeminal Neuralgia Therapeutics Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Trigeminal Neuralgia Therapeutics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Trigeminal Neuralgia Therapeutics Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Trigeminal Neuralgia Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Trigeminal Neuralgia Therapeutics Revenue Share by Players/Suppliers
Table United States Market Trigeminal Neuralgia Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Trigeminal Neuralgia Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Trigeminal Neuralgia Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Trigeminal Neuralgia Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Trigeminal Neuralgia Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Trigeminal Neuralgia Therapeutics Product Category
Table United States Trigeminal Neuralgia Therapeutics Sales (K Pcs) by Region (2013-2018)
Table United States Trigeminal Neuralgia Therapeutics Sales Share by Region (2013-2018)
Figure United States Trigeminal Neuralgia Therapeutics Sales Share by Region (2013-2018)
Figure United States Trigeminal Neuralgia Therapeutics Sales Market Share by Region in 2017
Table United States Trigeminal Neuralgia Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Trigeminal Neuralgia Therapeutics Revenue Share by Region (2013-2018)
Figure United States Trigeminal Neuralgia Therapeutics Revenue Market Share by Region (2013-2018)
Figure United States Trigeminal Neuralgia Therapeutics Revenue Market Share by Region in 2017
Table United States Trigeminal Neuralgia Therapeutics Price (USD/Pcs) by Region (2013-2018)
Table United States Trigeminal Neuralgia Therapeutics Sales (K Pcs) by Type (2013-2018)
Table United States Trigeminal Neuralgia Therapeutics Sales Share by Type (2013-2018)
Figure United States Trigeminal Neuralgia Therapeutics Sales Share by Type (2013-2018)
Figure United States Trigeminal Neuralgia Therapeutics Sales Market Share by Type in 2017
Table United States Trigeminal Neuralgia Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Trigeminal Neuralgia Therapeutics Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Trigeminal Neuralgia Therapeutics by Type (2013-2018)
Figure Revenue Market Share of Trigeminal Neuralgia Therapeutics by Type in 2017
Table United States Trigeminal Neuralgia Therapeutics Price (USD/Pcs) by Types (2013-2018)
Figure United States Trigeminal Neuralgia Therapeutics Sales Growth Rate by Type (2013-2018)
Table United States Trigeminal Neuralgia Therapeutics Sales (K Pcs) by Application (2013-2018)
Table United States Trigeminal Neuralgia Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Trigeminal Neuralgia Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Trigeminal Neuralgia Therapeutics Sales Market Share by Application in 2017
Table United States Trigeminal Neuralgia Therapeutics Sales Growth Rate by Application (2013-2018)
Figure United States Trigeminal Neuralgia Therapeutics Sales Growth Rate by Application (2013-2018)
Table Allergan, Inc. Basic Information List
Table Allergan, Inc. Trigeminal Neuralgia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Allergan, Inc. Trigeminal Neuralgia Therapeutics Sales Growth Rate (2013-2018)
Figure Allergan, Inc. Trigeminal Neuralgia Therapeutics Sales Market Share in United States (2013-2018)
Figure Allergan, Inc. Trigeminal Neuralgia Therapeutics Revenue Market Share in United States (2013-2018)
Table Biogen, Inc. Basic Information List
Table Biogen, Inc. Trigeminal Neuralgia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Biogen, Inc. Trigeminal Neuralgia Therapeutics Sales Growth Rate (2013-2018)
Figure Biogen, Inc. Trigeminal Neuralgia Therapeutics Sales Market Share in United States (2013-2018)
Figure Biogen, Inc. Trigeminal Neuralgia Therapeutics Revenue Market Share in United States (2013-2018)
Table Kineta, Inc. Basic Information List
Table Kineta, Inc. Trigeminal Neuralgia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Kineta, Inc. Trigeminal Neuralgia Therapeutics Sales Growth Rate (2013-2018)
Figure Kineta, Inc. Trigeminal Neuralgia Therapeutics Sales Market Share in United States (2013-2018)
Figure Kineta, Inc. Trigeminal Neuralgia Therapeutics Revenue Market Share in United States (2013-2018)
Table Merz Pharma GmbH & Co. KgaA Basic Information List
Table Merz Pharma GmbH & Co. KgaA Trigeminal Neuralgia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merz Pharma GmbH & Co. KgaA Trigeminal Neuralgia Therapeutics Sales Growth Rate (2013-2018)
Figure Merz Pharma GmbH & Co. KgaA Trigeminal Neuralgia Therapeutics Sales Market Share in United States (2013-2018)
Figure Merz Pharma GmbH & Co. KgaA Trigeminal Neuralgia Therapeutics Revenue Market Share in United States (2013-2018)
Table Trigemina, Inc. Basic Information List
Table Trigemina, Inc. Trigeminal Neuralgia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Trigemina, Inc. Trigeminal Neuralgia Therapeutics Sales Growth Rate (2013-2018)
Figure Trigemina, Inc. Trigeminal Neuralgia Therapeutics Sales Market Share in United States (2013-2018)
Figure Trigemina, Inc. Trigeminal Neuralgia Therapeutics Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Trigeminal Neuralgia Therapeutics
Figure Manufacturing Process Analysis of Trigeminal Neuralgia Therapeutics
Figure Trigeminal Neuralgia Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Trigeminal Neuralgia Therapeutics Major Players/Suppliers in 2017
Table Major Buyers of Trigeminal Neuralgia Therapeutics
Table Distributors/Traders List
Figure United States Trigeminal Neuralgia Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Trigeminal Neuralgia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Trigeminal Neuralgia Therapeutics Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Trigeminal Neuralgia Therapeutics Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Trigeminal Neuralgia Therapeutics Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Trigeminal Neuralgia Therapeutics Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Trigeminal Neuralgia Therapeutics Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Trigeminal Neuralgia Therapeutics Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Trigeminal Neuralgia Therapeutics Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Trigeminal Neuralgia Therapeutics Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Trigeminal Neuralgia Therapeutics Sales Volume Share Forecast by Region (2018-2025)
Figure United States Trigeminal Neuralgia Therapeutics Sales Volume Share Forecast by Region (2018-2025)
Figure United States Trigeminal Neuralgia Therapeutics Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources